Sanofi, Disc Will Be First To Test US FDA’s CNPV Pathway

 
• By Michael McCaughan
  
Two CNPV candidates already are under review and should provide the first test of the new FDA pathway. (Shutterstock)

More from Review Pathways

More from United States